Author Correction: Targeting myeloid-derived suppressor cells promotes antiparasitic T-cell immunity and enhances the efficacy of PD-1 blockade

Chuanshan Zhang^#^{1

2

3}, Hui Wang^#^{4

5

6}, Tuerganaili Aji^#^{5

7}, Zhide Li^#⁴, Yinshi Li^{4

8}, Abidan Ainiwaer^{4

8}, Zibigu Rousu^{4

8}, Jing Li⁸, Maolin Wang^{4

7}, Bingqing Deng^{4

8}, Adilai Duolikun^{4

8}, Xuejiao Kang^{4

8}, Xuran Zheng^{4

8}, Qian Yu^{4

8}, Yingmei Shao⁷, Wenbao Zhang^{4

6}, Dominique A Vuitton⁹, Zhigang Tian¹⁰, Haoyu Sun^{11

12

13}, Hao Wen¹⁴

Affiliations

¹ State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University; Clinical Medicine Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, P. R. China. dashan0518@126.com.
² Basic Medical College, Xinjiang Medical University, Urumqi, Xinjiang, P. R. China. dashan0518@126.com.
³ Key Laboratory of High Incidence Disease Research in Xingjiang, Ministry of Education, Xinjiang Medical University, Urumqi, Xinjiang, P. R. China. dashan0518@126.com.
⁴ State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University; Clinical Medicine Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, P. R. China.
⁵ Key Laboratory of High Incidence Disease Research in Xingjiang, Ministry of Education, Xinjiang Medical University, Urumqi, Xinjiang, P. R. China.
⁶ Xinjiang Key Laboratory of Echinococcosis, Clinical Medicine Research Institute, The First Affiliated Hospital of Xinjiang Medical University, and WHO Collaborating Centre on Prevention and Case Management of Echinococcosis, Urumqi, Xinjiang, P. R. China.
⁷ Department of Hepatic Hydatid and Hepatobiliary Surgery, Digestive and Vascular Surgery Centre, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, P. R. China.
⁸ Basic Medical College, Xinjiang Medical University, Urumqi, Xinjiang, P. R. China.
⁹ WHO-Collaborating Centre for the Prevention and Treatment of Human Echinococcosis, Department of Parasitology, University Bourgogne Franche-Comté (EA 3181) and University Hospital, Besançon, France.
¹⁰ Hefei National Research Center for Physical Sciences at Microscale, the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, P. R. China.
¹¹ Hefei National Research Center for Physical Sciences at Microscale, the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, P. R. China. haoyusun@ustc.edu.cn.
¹² Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China. haoyusun@ustc.edu.cn.
¹³ Institute of Immunology, University of Science and Technology of China, Hefei, Anhui, P. R. China. haoyusun@ustc.edu.cn.
¹⁴ State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University; Clinical Medicine Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, P. R. China. Dr.wenhao@163.com.

^# Contributed equally.

PMID: 39191752
PMCID: PMC11350002
DOI: 10.1038/s41467-024-51832-6

Published Erratum

Author Correction: Targeting myeloid-derived suppressor cells promotes antiparasitic T-cell immunity and enhances the efficacy of PD-1 blockade

Chuanshan Zhang et al. Nat Commun. 2024.

. 2024 Aug 27;15(1):7374.

doi: 10.1038/s41467-024-51832-6.

Authors

Affiliations

¹ State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University; Clinical Medicine Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, P. R. China. dashan0518@126.com.
² Basic Medical College, Xinjiang Medical University, Urumqi, Xinjiang, P. R. China. dashan0518@126.com.
³ Key Laboratory of High Incidence Disease Research in Xingjiang, Ministry of Education, Xinjiang Medical University, Urumqi, Xinjiang, P. R. China. dashan0518@126.com.
⁴ State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University; Clinical Medicine Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, P. R. China.
⁵ Key Laboratory of High Incidence Disease Research in Xingjiang, Ministry of Education, Xinjiang Medical University, Urumqi, Xinjiang, P. R. China.
⁶ Xinjiang Key Laboratory of Echinococcosis, Clinical Medicine Research Institute, The First Affiliated Hospital of Xinjiang Medical University, and WHO Collaborating Centre on Prevention and Case Management of Echinococcosis, Urumqi, Xinjiang, P. R. China.
⁷ Department of Hepatic Hydatid and Hepatobiliary Surgery, Digestive and Vascular Surgery Centre, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, P. R. China.
⁸ Basic Medical College, Xinjiang Medical University, Urumqi, Xinjiang, P. R. China.
⁹ WHO-Collaborating Centre for the Prevention and Treatment of Human Echinococcosis, Department of Parasitology, University Bourgogne Franche-Comté (EA 3181) and University Hospital, Besançon, France.
¹⁰ Hefei National Research Center for Physical Sciences at Microscale, the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, P. R. China.
¹¹ Hefei National Research Center for Physical Sciences at Microscale, the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, P. R. China. haoyusun@ustc.edu.cn.
¹² Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China. haoyusun@ustc.edu.cn.
¹³ Institute of Immunology, University of Science and Technology of China, Hefei, Anhui, P. R. China. haoyusun@ustc.edu.cn.
¹⁴ State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University; Clinical Medicine Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, P. R. China. Dr.wenhao@163.com.

^# Contributed equally.

PMID: 39191752
PMCID: PMC11350002
DOI: 10.1038/s41467-024-51832-6

No abstract available

PubMed Disclaimer

Erratum for

Targeting myeloid-derived suppressor cells promotes antiparasitic T-cell immunity and enhances the efficacy of PD-1 blockade (15 words).
Zhang C, Wang H, Aji T, Li Z, Li Y, Ainiwaer A, Rousu Z, Li J, Wang M, Deng B, Duolikun A, Kang X, Zheng X, Yu Q, Shao Y, Zhang W, Vuitton DA, Tian Z, Sun H, Wen H. Zhang C, et al. Nat Commun. 2024 Jul 27;15(1):6345. doi: 10.1038/s41467-024-50754-7. Nat Commun. 2024. PMID: 39068159 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Targeting myeloid-derived suppressor cells promotes antiparasitic T-cell immunity and enhances the efficacy of PD-1 blockade

Affiliations

Author Correction: Targeting myeloid-derived suppressor cells promotes antiparasitic T-cell immunity and enhances the efficacy of PD-1 blockade

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources